Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.
A dangerous bird flu, in other words, was suddenly circulating in mammals — mammals with which people have ongoing, extensive ...
New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback